Global Proteomics Market is estimated to value over USD 36 billion by 2026 end and register a CAGR of over 12.9% during the forecast period 2019 to 2026.
The global proteomics market growth is steered by increased research activities, specifically in the fields of drug discovery and personalized medicine. Furthermore, factors such as increasing expenditure for research and development activities in biotechnology and pharmaceutical companies, financial back up by the government for proteomics and advancements in technology.
The reagents segment is predicted to account for the largest global proteomics market share in 2018. This domination can be credited to the rising usage of different reagents for the separation of protein from complicated mixtures and other procedures used for proteome analysis, thus resulting in an efficient analysis.
The drug discovery segment is projected to dominate the market over the forecast period. The proteomics technology minimizes the time, resource and cost requirements of the biological drug testing and synthesis of chemicals. These technologies offer extensive details of biological and chemical information about targets and ligands that are used to optimize and identify new and innovative drugs. These factors have helped in simplifying the drug development and discovery process using computational methodologies, which, in turn, has propelled the adoption of proteomics methods in drug development and discovery.
The Asia Pacific region is projected to proliferate with a substantial growth rate over the forecast period. The research industry related to life sciences in Latin America is mainly steered by increased research in proteomics, specifically in cancer, infectious disease areas and neurobiology and the increased use of novel methodologies in different sectors, for instance, protein analysis drug designing and disease pathway determination.
Key market players are Thermo Fisher Scientific, Inc., Agilent Technologies, Inc., Merck KGaA, Danaher Corporation, Waters Corporation, Bio-Rad Laboratories, Inc., Bruker Corporation, GE Healthcare, Perkinelmer, Inc., Luminex Corporation, Creative Proteomics, Promega Corporation.
Waters Corporation acquired the patent of Desorption Electrospray Ionization (DESI) technology, in June 2018, for all applications of mass spectrometry from the Purdue Research Foundation. Likewise, Thermo Fisher Scientific Inc. in February 2017, acquired Finesse Solutions, a company based in California and leading developer of control automation software and systems for bio production. It was expected that Thermo Fisher’s Life Sciences Solutions Segment shall be integrated through this business in order to optimize the workflow of bio production. Furthermore, Thermo Scientific and Evosep partnered, in June 2018, to promote and develop high-throughput, robust clinical proteomics workflows at the 66th Conference on Allied Topics and Mass Spectrometry.
Request a Sample Report @ https://www.futurewiseresearch.com/request-sample.aspx?id=3450&page=requestsample
Global Proteomics Market Segmentation:
By Instrumentation Technology
• Spectroscopy
- Mass Spectroscopy
- NMR Spectroscopy
- CD Spectroscopy
• Chromatography
- HPLC
- Ion Chromatography
- Affinity Chromatography
- Supercritical Fluid Chromatography
• Electrophoresis
- Gel Electrophoresis
- Capillary Electrophoresis
• Protein Microarrays
- Biochips
• Lab-On-Chips (Microfludics)
• Protein Chips
- Microarray Instruments
~ Integrated Systems
~ Microarray Scanners
~ Arrayers
• X-ray Crystallography
• Surface Plasmon Resonance
• Protein Fractionation
By Reagent
• Immunoassay Reagents
• Spectroscopy Reagents
• Chromatography Reagents
• Protein Microarray Reagents
• X-Ray Crystallography Reagents
• Electrophoresis Reagents
• Protein Fractionation Reagents
By Service & Software
• Core Proteomics Services
- Protein Identification
- Protein Characterization Services
- Quantitative Proteomics Services
- Protein Purification
- Protein Separation
- Protein Sequencing Services
- Custom Assay Services
• Bioinformation Software & Services
- Bioinformatics Services
- Bioinformatics Tools
- Bioinformatics Databases
By Application
• Clinical Diagnostics
• Drug Discovery
• Other Applications
By Region
• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa
Purchase a Copy & Ask For Discount: https://www.futurewiseresearch.com/request-sample.aspx?id=3450&page=askfordiscount

FutureWise Key Takeaways:
• Growth prospects
• SWOT analysis
• Key trends
• Key data-points affecting market growth
Objectives of the Study:
• To provide with an exhaustive analysis on the global proteomics market by instrumentation technology, by reagent, by service & software, by application and by region
• To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
• To evaluate and forecast micro-markets and the overall market
• To predict the market size, in key regions (along with countries)— North America, Europe, Asia Pacific, Latin America and Middle East & Africa
• To record evaluate and competitive landscape mapping- product launches, technological advancements, mergers and expansions
• Profiling of companies to evaluate their market shares, strategies, financials and core competencies

Browse Corresponding Healthcare Market Research Reports& Consulting

Inquire further details about this report at: [email protected]

About FutureWise Research:
We specialise in high-growth niche markets, assuring flexibility, agility and customised solutions for our clients. Through in-depth market insights and consultancy, we present our clients with the tools they need to be at the forefront of their industry – a position secured for far more than the near future.

Contact Us:
Company Name: FutureWise Research
Contact Person: Vinay Thaploo
Email: [email protected]
Phone: +44 141 628 9353 / +1 970 279 4295
City: Leeds
Country: United Kingdom
Website: www.futurewiseresearch.com